Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

Name: Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

type 2 diabetes

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 267987
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.